Stockscreener 앱 받기
1.55
0.64%
-0.01
전일 마감가:
$1.56
열려 있는:
$1.57
하루 거래량:
83,574
Relative Volume:
0.21
시가총액:
$41.07M
수익:
$155.00K
순이익/손실:
$-30.01M
주가수익비율:
-0.9281
EPS:
-1.67
순현금흐름:
$-11.98M
1주 성능:
-0.64%
1개월 성능:
-18.85%
6개월 성능:
-32.61%
1년 성능:
-72.17%
1일 변동 폭
$1.54
$1.6099
1주일 범위
$1.47
$1.63
52주 변동 폭
$1.38
$11.64
Inmune Bio Inc Stock (INMB) Company Profile
명칭
Inmune Bio Inc
전화
(858) 964-3720
주소
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA
INMB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INMB
Inmune Bio Inc
|
1.545 | 41.47M | 155.00K | -30.01M | -11.98M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
482.70 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
805.00 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.33 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
817.59 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.80 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Inmune Bio Inc Stock (INMB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-01 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-07-01 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Underperform |
| 2025-01-28 | 개시 | Rodman & Renshaw | Buy |
| 2024-10-21 | 개시 | Alliance Global Partners | Buy |
| 2024-09-27 | 개시 | Raymond James | Outperform |
| 2024-08-22 | 개시 | Scotiabank | Sector Outperform |
| 2023-06-01 | 개시 | Robert W. Baird | Outperform |
| 2022-05-24 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2021-07-07 | 재확인 | Maxim Group | Buy |
| 2021-04-21 | 개시 | B. Riley Securities | Buy |
| 2021-01-22 | 재확인 | Maxim Group | Buy |
| 2020-09-01 | 개시 | BTIG Research | Buy |
| 2020-07-15 | 재확인 | H.C. Wainwright | Buy |
모두보기
Inmune Bio Inc 주식(INMB)의 최신 뉴스
Aug EndMonth: Will INmune Bio Inc stock outperform Dow Jones indexLong Setup & Verified Momentum Watchlists - moha.gov.vn
Can INmune Bio Inc. stock withstand economic slowdown2026 world cup usa national team round of 32 defensive leaders low block defense expert forecast expert opinion - Улправда
INmune Bio Inc Stock Analysis and ForecastTechnology Stock Trends & Exceptional Capital Growth - earlytimes.in
How INmune Bio Inc. stock performs in high volatility marketsEnergy Sector Updates & Small Investment Capital Tips - bollywoodhelpline.com
Inmune Bio Amends April 2024 Investor Warrants - TipRanks
INMB (INmune Bio) EV-to-OCF : -0.76 (As of Dec. 22, 2025) - GuruFocus
INMB (INmune Bio) EV-to-FCF : -0.75 (As of Dec. 22, 2025) - GuruFocus
Aug Wrap: How interest rate cuts could boost INmune Bio Inc stockQuarterly Earnings Summary & Real-Time Buy Signal Notifications - moha.gov.vn
Winners Losers: What is the fair value of INmune Bio Inc stock nowChart Signals & Accurate Trade Setup Notifications - moha.gov.vn
Gains Report: Is INmune Bio Inc stock a top pick in earnings seasonQuarterly Portfolio Review & Weekly Watchlist of Top Performers - moha.gov.vn
Why analysts upgrade INmune Bio Inc. stockMarket Performance Recap & Expert Curated Trade Ideas - Улправда
INmune Bio Establishes $65 Million At-The-Market Offering - The Globe and Mail
Is INmune Bio Inc. stock vulnerable to regulatory risksMarket Weekly Review & AI Forecasted Stock Moves - Улправда
Will INmune Bio Inc. stock attract more institutional investorsLayoff News & Smart Money Movement Alerts - Улправда
Aug Highlights: Is INmune Bio Inc. stock attractive for long term wealth buildingWeekly Trading Summary & Verified Technical Trade Signals - Улправда
INMune Bio establishes $65 million at-the-market offering - MSN
Is INmune Bio Inc. stock a good choice for value investorsRecession Risk & Real-Time Buy Zone Alerts - Улправда
INmune Bio Signs Sales Agreement With A.G.P./Alliance Global Partners - TradingView — Track All Markets
Is INmune Bio Inc. stock resilient to inflation2025 Fundamental Recap & Community Verified Trade Alerts - DonanımHaber
INmune Bio Stock Slumps After Alzheimer’s Drug Falls Short In Mid-Stage Trial - MSN
Is INmune Bio Inc. stock a top pick in earnings season2025 Volatility Report & Consistent Income Trade Ideas - DonanımHaber
INmune Bio Shares Collapse After Mixed Results from Alzheimer’s Drug Trial - MSN
INmune Bio Earnings Notes - Trefis
INmune Bio (NASDAQ:INMB) Rating Increased to Hold at Wall Street Zen - MarketBeat
Aug Closing: Is INmune Bio Inc stock resilient to inflationTrade Risk Report & Expert Verified Movement Alerts - moha.gov.vn
Praetorian PR LLC Sells 863,000 Shares of INmune Bio, Inc. $INMB - MarketBeat
Inmune Bio to Host Q3 Results Conference Call - MSN
Inmune Bio Reports Q3 2025 Financial Results - MSN
Inmune Bio Ends Sales Agreement with RBC and BTIG - TipRanks
Can INmune Bio Stock Hold Up When Markets Turn? - Trefis
Can INmune Bio (NASDAQ:INMB) Afford To Invest In Growth? - Sahm
Would You Still Hold INmune Bio Stock If It Fell 30%? - Trefis
Inmune Bio Unveils Promising Alzheimer’s Trial Data - MSN
Insider Sell: Why INmune Bio Inc stock could see breakout soonJuly 2025 Momentum & AI Enhanced Market Trend Forecasts - moha.gov.vn
Retail Trends: Can INmune Bio Inc stock beat analyst upgradesMarket Activity Report & Verified Chart Pattern Signals - BỘ NỘI VỤ
Peer Reviewed Study Highlights Therapeutic Potential Around Application of Stromal Cell Therapies Such as Inmune Bio's CORDStrom?? Platform - marketscreener.com
INMB: INmune Bio Highlights Future Potential of MSC Therapies - GuruFocus
INmune Bio, Inc. Announces Publication on Future Applications of Mesenchymal Stromal Cell Therapies - Quiver Quantitative
Peer Reviewed Study Highlights Therapeutic Potential Around Application of Stromal Cell Therapies Such as INmune Bio’s CORDStrom™ Platform - The Manila Times
Inmune Bio Updates Executive Employment Agreements - TipRanks
INMB SEC FilingsInmune Bio Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Could INmune Bio Unlock Value With Upcoming Regulatory Catalysts And Clinical Readouts? - RTTNews
Why INmune Bio Inc. stock could see breakout soonWeekly Loss Report & Daily Momentum Trading Reports - Newser
Can INmune Bio Inc. stock beat analyst upgradesStock Surge & Free Technical Confirmation Trade Alerts - Newser
Can INmune Bio Stock Recover If Markets Fall? - Trefis
Can INmune Bio Inc. stock sustain revenue growthJuly 2025 News Drivers & AI Powered Buy and Sell Recommendations - Newser
INmune Bio reports promising Alzheimer’s drug data at CTAD conference By Investing.com - Investing.com Canada
Inmune Bio Inc (INMB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.06%
0.08%
자본화:
|
볼륨(24시간):